We’re thrilled to partner with the University of California, San Diego for FDA testing of ZipThaw.
We’re thrilled to partner with the University of California, San Diego for FDA testing of ZipThaw.
Today Fred Thacher, CEO and co-founder of FreMon Scientific, oversaw continued predicate testing of fresh frozen plasma devices at the San Diego Blood Bank.
FMS, led by co-founder Fred Thacher, attends the 2018 AABB in Boston this week. (more…)
FDA testing of ZipThaw requires us to set up a predicate plasma thawing device. We’re thrilled to be partnering with the San Diego Blood Bank on this critical data gathering and benchmarking phase.
FreMon Scientific, in preparation for a second European Union CE Mark medical device audit, is in the pre-production assembly line development stage.
We’re entering a bold new phase.
San Diego Blood Bank has agreed to test ZipThaw and ZipSleeve devices.
We’re grateful for the San Diego Blood Bank’s guidance with ZipThaw.
FreMon Scientific filed a 510(k) application with the FDA for ZipThaw202 and ZipSleeve.
ZipThaw and ZipSleeve technology is now protected with a total of 6 patents having been filed.
We’re deep into the FDA and CE Mark approval process for ZipThaw.
After many months of development, Moni Shavit and Fred Thacher of FreMon Scientific announce an updated ZipThaw blood and tissue thawing and warming medical device, designed in partnership with Aran R&D in Caesarea, Israel.
We have big news to share. Yesterday FreMon Scientific passed a key CE Mark milestone with ZipThaw and ZipSleeve.
FMS is honored to welcome the San Diego Blood Bank to the FreMon Scientific family of companies and academic centers assisting with and guiding the development of this new generation technology for warming and thawing blood and tissue products.
ZipThaw and ZIpSleeve have advanced from prototype to nearly production ready.
ZipThaw202 will be the first to market next generation technology blood and tissue products warming device and disposable.
FreMon Scientific, developer of ZipThaw and ZipSleeve next gen blood & tissue products warming and thawing technology, has submitted the Form 510(K) to the FDA and will have the initial CE Mark audit performed by the European Union on June 3.
Recently at the UN, FreMon Scientific’s co-founder Fred Thacher had a front row seat and introduction to UN Ambassador Nikki Haley. We’re engaging with the UN as we seek global distribution for our next gen blood & tissue thawing device, ZipThaw.
Aran R&D and FMS continue their collaboration with the San Diego Blood Back to perfect the ZipThaw and ZipSleeve prototypes.